DURTIMA Trademark

Trademark Overview


On Wednesday, November 28, 2012, a trademark application was filed for DURTIMA with the United States Patent and Trademark Office. The USPTO has given the DURTIMA trademark a serial number of 85789535. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 13, 2023. This trademark is owned by Glaxo Group Limited. The DURTIMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculo...
durtima

General Information


Serial Number85789535
Word MarkDURTIMA
Filing DateWednesday, November 28, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 13, 2023
Registration Number4986098
Registration DateTuesday, June 28, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 30, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "DURTIMA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, January 13, 2023CANCELLED SEC. 8 (6-YR)
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 28, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, May 24, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Monday, May 23, 2016NOTICE OF ALLOWANCE CANCELLED
Monday, May 23, 2016TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, December 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 30, 2015SOU EXTENSION 5 GRANTED
Wednesday, November 18, 2015SOU EXTENSION 5 FILED
Wednesday, November 18, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015SOU EXTENSION 4 GRANTED
Monday, June 1, 2015SOU EXTENSION 4 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Wednesday, December 3, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 2, 2014SOU EXTENSION 3 GRANTED
Thursday, November 20, 2014SOU EXTENSION 3 FILED
Thursday, November 20, 2014TEAS EXTENSION RECEIVED
Thursday, June 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2014SOU EXTENSION 2 GRANTED
Thursday, May 22, 2014SOU EXTENSION 2 FILED
Tuesday, June 10, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 22, 2014TEAS EXTENSION RECEIVED
Friday, December 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2013SOU EXTENSION 1 GRANTED
Wednesday, December 11, 2013SOU EXTENSION 1 FILED
Wednesday, December 11, 2013TEAS EXTENSION RECEIVED
Tuesday, June 25, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 30, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 10, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 13, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 7, 2013ASSIGNED TO EXAMINER
Thursday, December 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 1, 2012NEW APPLICATION ENTERED